Market revenue in 2022 | USD 1,470.4 million |
Market revenue in 2030 | USD 2,470.2 million |
Growth rate | 6.7% (CAGR from 2022 to 2030) |
Largest segment | Gelatin-based/animal-based |
Fastest growing segment | Non-Animal-Based |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Gelatin-Based/Animal-Based, Non-Animal-Based |
Key market players worldwide | Thermo Fisher Scientific Inc, EyePoint Pharmaceuticals Inc, Catalent Inc, Kuehne + Nagel International AG, Lonza Group Ltd, Procaps Group SA, Soft Gel Technologies, EuroCaps, Captek Softgel International, Sirio Pharma, Fuji Capsule |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to softgel capsules market will help companies and investors design strategic landscapes.
Gelatin-based/animal-based was the largest segment with a revenue share of 72.01% in 2022. Horizon Databook has segmented the Europe softgel capsules market based on gelatin-based/animal-based, non-animal-based covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe softgel capsules market , including forecasts for subscribers. This continent databook contains high-level insights into Europe softgel capsules market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account